Resultados de la búsqueda 401-410 of 12879 for Aspergillosis

  1. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

  2. Hematología - Ensayos clínicos

    This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the ...

  3. Oncología (médica) - Ensayos clínicos

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...

  4. Centro Pediátrico de Mayo Clinic

    The aim of this study is to test the validity of the current question database in a large cohort of children with Inflammatory Bowel Disease (IBD) in several ...

  5. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...

  6. Gastroenteritis: primeros auxilios - Mayo Clinic

    Virus; Alimentos o agua contaminados por bacterias o parásitos; Efectos secundarios de los medicamentos. Náuseas y vómitos; Diarrea; Calambres abdominales ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy, and ...

  8. Hematología - Ensayos clínicos

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ( ...

  9. Oncología (médica) - Ensayos clínicos

    For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...

  10. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...